Shavers-Hornaday VL, Lynch CF, Burmeister LF, Torner JC. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health. 1997;2:31–45.
The 1000 Genomes Project Consortium, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.
Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nature. 2016;538:161–164.
Millon Underwood S, Buseh AG, Kelber ST, Stevens PE, Townsend L. Enhancing the participation of African Americans in health-related genetic research: findings of a collaborative academic and community-based research study. Nurs Res Pract. 2013;2013:749563.
Halbert CH, McDonald J, Vadaparampil S, Rice L, Jefferson M. Conducting precision medicine research with African Americans. PLoS ONE. 2016;11:e0154850.
Yu JH, Crouch J, Jamal SM, Tabor HK, Bamshad MJ. Attitudes of African Americans toward return of results from exome and whole genome sequencing. Am J Med Genet A. 2013;161A:1064–1072.
Sanderson SC, Diefenbach MA, Zinberg R, et al. Willingness to participate in genomics research and desire for personal results among underrepresented minority patients: a structured interview study. J Community Genet. 2013;4:469–482.
McDonald JA, Barg FK, Weathers B, et al. Understanding participation by African Americans in cancer genetics research. J Natl Med Assoc. 2012;104:324–330.
Bustamante CD, Burchard EG, De La Vega FM. Genomics for the world. Nature. 2011;475:163–165.
National Institutes of Health. NIH accelerates the use of genomics in clinical care: new funding awards focus on diverse and underserved populations. 2017. https://www.nih.gov/news-events/news-releases/nih-accelerates-use-genomics-clinical-care. Accessed 6 December 2017.
The Precision Medicine Initiative Cohort Program – Building a Research Foundation for 21st Century Medicine. 2015. https://acd.od.nih.gov/documents/reports/DRAFT-PMI-WG-Report-9-11-2015-508.pdf. Accessed 29 October 2018.
Wailoo K. Sickle cell disease—a history of progress and peril. N Engl J Med. 2017;376:805–807.
Sanderson SC, Linderman MD, Suckiel SA, et al. Motivations, concerns and preferences of personal genome sequencing research participants: baseline findings from the HealthSeq project. Eur J Hum Genet. 2016;24:14–20.
Roberts JS, Robinson JO, Diamond PM, et al. Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project. Genet Med. 2018 Jan 4; [Epub ahead of print].
Kauffman TL, Irving SA, Leo MC, et al. The NextGen Study: patient motivation for participation in genome sequencing for carrier status. Mol Genet Genomic Med. 2017;5:508–515.
Gray SW, Park ER, Najita J, et al. Oncologists’ and cancer patients’ views on whole-exome sequencing and incidental findings: results from the CanSeq study. Genet Med. 2016;18:1011–1019.
Schmidlen TJ, Scheinfeldt L, Zhaoyang R, et al. Genetic knowledge among participants in the Coriell Personalized Medicine Collaborative. J Genet Couns. 2016;25:385–394.
Biesecker LG, Mullikin JC, Facio FM, et al. The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res. 2009;19:1665–1674.
Lewis KL, Han PK, Hooker GW, Klein WM, Biesecker LG, Biesecker BB. Characterizing participants in the ClinSeq Genome Sequencing Cohort as early adopters of a new health technology. PLoS ONE. 2015;10:e0132690.
Kaphingst KA, Facio FM, Cheng MR, et al. Effects of informed consent for individual genome sequencing on relevant knowledge. Clin Genet. 2012;82:408–415.
Facio FM, Brooks S, Loewenstein J, Green S, Biesecker LG, Biesecker BB. Motivators for participation in a whole-genome sequencing study: implications for translational genomics research. Eur J Hum Genet. 2011;19:1213–1217.
James RD, Yu JH, Henrikson NB, Bowen DJ, Fullerton SM, Health Disparities Working Group. Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet. 2008;11:241–249.
Johnson VA, Powell-Young YM, Torres ER, Spruill IJ. A systematic review of strategies that increase the recruitment and retention of African American adults in genetic and genomic studies. ABNF J. 2011;22:84–88.
Hughes C, Peterson SK, Ramirez A, et al. Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev. 2004;13:1146–1155.
Geller G, Tambor ES, Chase GA, Holtzman NA. Measuring physicians’ tolerance for ambiguity and its relationship to their reported practices regarding genetic testing. Med Care. 1993;31:989–1001.
Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994;67:1063–1078.
Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-Davidson Resilience Scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress. 2007;20:1019–1028.
John OP, Srivastava S. The Big-Five trait taxonomy: history, measurement and theoretical perspectives. In: Pervin LA, Johns OP, eds. Handbook of personality: theory and research. Vol. 2. New York: Guilford Press; 1999. p. 102–138.
Schaa KL, Roter DL, Biesecker BB, Cooper LA, Erby LH. Genetic counselors’ implicit racial attitudes and their relationship to communication. Health Psychol. 2015;34:111–119.
FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18:19.
Marteau T, Dormandy E, Michie S. A measure of informed choice. Health Expect. 2001;4:99–108.
Waters EA, Hay JL, Orom H, Kiviniemi MT, Drake BF. “Don’t know” responses to risk perception measures: implications for underserved populations. Med Decis Making. 2013;33:271–281.
Bruttomesso D, Gagnayre R, Leclercq D, et al. The use of degrees of certainty to evaluate knowledge. Patient Educ Couns. 2003;51:29–37.
Gollust SE, Gordon ES, Zayac C, et al. Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics. 2012;15:22–30.
Koehly LM, Peterson SK, Watts BG, Kempf KK, Vernon SW, Gritz ER. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev. 2003;12:304–313.
Peay HL, Scharff H, Tibben A, et al. “Watching time tick by…”: decision making for Duchenne muscular dystrophy trials. Contemp Clin Trials. 2016;46:1–6.
Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003.
Claes E, Denayer L, Evers-Kiebooms G, et al. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Test. 2005;9:54–65.